Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Catabolite repression of SOS-dependent and SOS-independent spontaneous mutagenesis in stationary-phase Escherichia coli.

MacPhee DG, Ambrose M.

Mutat Res. 2010 Apr 1;686(1-2):84-9. doi: 10.1016/j.mrfmmm.2010.01.022. Epub 2010 Feb 6.

PMID:
20138895
2.

Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.

Yano M, Hamatani K, Eguchi H, Hirai Y, MacPhee DG, Sugino K, Dohi K, Itamoto T, Asahara T.

Eur J Cancer. 2007 Apr;43(6):1092-100. Epub 2007 Mar 12.

PMID:
17350822
3.
4.

Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.

Hirai Y, Kodama Y, Moriwaki S, Noda A, Cullings HM, Macphee DG, Kodama K, Mabuchi K, Kraemer KH, Land CE, Nakamura N.

Mutat Res. 2006 Oct 10;601(1-2):171-8. Epub 2006 Aug 14.

PMID:
16905156
5.

Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.

Nagasaka T, Sasamoto H, Notohara K, Cullings HM, Takeda M, Kimura K, Kambara T, MacPhee DG, Young J, Leggett BA, Jass JR, Tanaka N, Matsubara N.

J Clin Oncol. 2004 Nov 15;22(22):4584-94.

PMID:
15542810
6.

Anisomycin downregulates gap-junctional intercellular communication via the p38 MAP-kinase pathway.

Ogawa T, Hayashi T, Kyoizumi S, Kusunoki Y, Nakachi K, MacPhee DG, Trosko JE, Kataoka K, Yorioka N.

J Cell Sci. 2004 Apr 15;117(Pt 10):2087-96. Epub 2004 Mar 30.

7.

Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.

Kambara T, Sharp GB, Nagasaka T, Takeda M, Sasamoto H, Nakagawa H, Isozaki H, MacPhee DG, Jass JR, Tanaka N, Matsubara N.

Clin Cancer Res. 2004 Mar 1;10(5):1758-63.

8.

Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.

Nagasaka T, Sharp GB, Notohara K, Kambara T, Sasamoto H, Isozaki H, MacPhee DG, Jass JR, Tanaka N, Matsubara N.

Clin Cancer Res. 2003 Nov 1;9(14):5306-12.

9.

Long-lasting changes in the T-cell receptor V beta repertoires of CD4 memory T-cell populations in the peripheral blood of radiation-exposed people.

Kusunoki Y, Yamaoka M, Kasagi F, Hayashi T, MacPhee DG, Kyoizumi S.

Br J Haematol. 2003 Sep;122(6):975-84.

PMID:
12956769
10.

Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors.

Hayashi T, Kusunoki Y, Hakoda M, Morishita Y, Kubo Y, Maki M, Kasagi F, Kodama K, Macphee DG, Kyoizumi S.

Int J Radiat Biol. 2003 Feb;79(2):129-36.

PMID:
12569016
11.
12.

Characterization of mutant clones lacking T-cell receptor alleles in a cell line from an adult T-cell leukaemia patient.

Kusunoki Y, Kyoizumi S, Umeki S, Hirai Y, MacPhee DG.

Br J Haematol. 2001 Aug;114(2):485-7. No abstract available.

PMID:
11529874
13.

Possible role of natural killer cells in negative selection of mutant lymphocytes that fail to express the human leukocyte antigen-A2 allele.

Kusunoki Y, Kyoizumi S, Kubo Y, Hayashi T, MacPhee DG.

Mutat Res. 2001 May 9;476(1-2):123-32.

PMID:
11336989
14.

Chromosomal instability in BRCA1- or BRCA2-defective human cancer cells detected by spontaneous micronucleus assay.

Ban S, Shinohara T, Hirai Y, Moritaku Y, Cologne JB, MacPhee DG.

Mutat Res. 2001 Mar 1;474(1-2):15-23.

PMID:
11239959
15.

Reflections in mutation research. Reflections of Zhores Medvedev.

Hoffmann GR, MacPhee DG.

Mutat Res. 2000 Jan;462(1):1-2. No abstract available.

PMID:
10681223
16.

Specific inhibition of the eubacterial DNA ligase by arylamino compounds.

Ciarrocchi G, MacPhee DG, Deady LW, Tilley L.

Antimicrob Agents Chemother. 1999 Nov;43(11):2766-72.

17.

Reflections in mutation research: an introductory essay.

Hoffmann GR, MacPhee DG.

Mutat Res. 1999 Mar;436(2):123-30. Review. No abstract available.

PMID:
10095135
18.
19.

The environmental and health effects of solar radiation.

MacPhee DG.

Mutat Res. 1998 Nov 9;422(1):1-6. No abstract available.

PMID:
9920422
20.

Why are there more mutations in males?

MacPhee DG, Murray ND.

Mutat Res. 1998 Jul 17;403(1-2):265-7. Review. No abstract available.

PMID:
9726027
21.
22.

Time-dependent mutagenesis and cancer: a new role for antimutagenesis in cancer prevention?

MacPhee DG.

Mutat Res. 1998 Jun 18;402(1-2):29-39. Review.

PMID:
9675238
24.

Frameshift mutagenesis by 9-aminoacridine: antimutagenic effects of adenosine compounds.

Kopsidas G, MacPhee DG.

Mutat Res. 1996 Jun 10;352(1-2):135-42.

PMID:
8676902
25.

Mismatch repair as an important source of new mutations in non-dividing cells.

MacPhee DG.

Experientia. 1996 Apr 15;52(4):357-63. Review.

PMID:
8620941
26.

Mismatch repair as a source of mutations in non-dividing cells.

MacPhee DG.

Genetica. 1996 Mar;97(2):183-95. Review.

PMID:
8901138
27.

Spontaneous mutations in bacteria: chance or necessity?

MacPhee DG, Ambrose M.

Genetica. 1996 Jan;97(1):87-101. Review.

PMID:
8851883
28.

Mismatch repair, somatic mutations, and the origins of cancer.

MacPhee DG.

Cancer Res. 1995 Dec 1;55(23):5489-92.

29.

Regulatory processes and the origins of spontaneous mutations.

MacPhee DG.

Mutat Res. 1994 May 1;307(1):115-20. Review.

PMID:
7513787
30.
31.

Is there evidence for directed mutation in bacteria?

MacPhee DG.

Mutagenesis. 1993 Jan;8(1):3-5. No abstract available.

PMID:
8450764
33.

Directed mutation: paradigm postponed.

MacPhee DG.

Mutat Res. 1993 Jan;285(1):109-16. Review.

PMID:
7678124
34.

Glucose inhibition of mutagenesis by 9-aminoacridine in Salmonella typhimurium.

Kopsidas G, MacPhee DG.

Mutat Res. 1993 Jan;285(1):101-8.

PMID:
7678123
35.

Substitution of animals in toxicology testing--a rush to judgement?

MacPhee DG.

Med J Aust. 1992 Feb 3;156(3):223-4. No abstract available.

PMID:
1545735
39.

Mutagenesis by the anti-tumour drug nitracrine in Escherichia coli.

MacPhee DG, Liaskou D.

Mutat Res. 1989 Dec;227(4):251-5.

PMID:
2685595
40.

Modulation of mutagenesis involving precise excision of transposon Tn10.

Hafner LM, MacPhee DG.

Mutat Res. 1989 Apr;211(2):291-9.

PMID:
2538730
41.

Development of bacterial mutagenicity tests: a view from afar.

MacPhee DG.

Environ Mol Mutagen. 1989;14 Suppl 16:35-8.

PMID:
2659329
42.
43.

The role of blood platelets in nucleoside metabolism: regulation of platelet thymidine phosphorylase.

Shaw T, Smillie RH, Miller AE, MacPhee DG.

Mutat Res. 1988 Jul-Aug;200(1-2):117-31.

PMID:
3134612
44.
45.

Frameshift mutagenesis by chloroquine in Escherichia coli and Salmonella typhimurium.

Thomas SM, Silburn KA, MacPhee DG.

Mutat Res. 1987 Dec;192(4):233-7.

PMID:
2446128
46.

RecA-independent mutagenesis in Escherichia coli may be subject to glucose repression.

Thomas SM, MacPhee DG.

Mutat Res. 1987 Sep;180(1):67-73.

PMID:
3041205
47.
49.

RecA-independent mutagenesis in Escherichia coli: effects of umuC and mucB mutations.

Thomas SM, MacPhee DG.

Mutagenesis. 1986 May;1(3):191-4.

PMID:
2842574
50.

Avoidance of errors after DNA damage.

MacPhee DG.

Basic Life Sci. 1986;39:201-3. No abstract available.

PMID:
3533042

Supplemental Content

Loading ...
Support Center